KPTI 8-K 2026-11-05

Karyopharm Therapeutics Inc. (KPTI) 8-K dated 2026-11-05 — accession 0001193125-26-448516.

Karyopharm Therapeutics Inc. (KPTI) is a biotechnology company listed on US.

Karyopharm Therapeutics Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-448516.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported KPTI revenue for 2025-12-31 was $146.1M. Net income was -$196.0M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. KPTI currently screens at market cap $205.6M.

Not investment advice. The KPTI SEC hub lists recent forms. The stock page is the research view.